Members

Peter Rugg-Gunn

Group Leader and Head of Public Engagement

Adam Bendall

PhD Student

Sarah Elderkin

Senior Research Scientist

Andrew Malcolm

Postdoc Research Scientist

Andrea Palomar

Visiting Scientist

Maria Rostovskaya

Senior Research Scientist

Yang Wang

Postdoc Research Scientist

Thomas Willday

Research Assistant

Richard Acton

Data Outputs Manager

Louis Coussement

Visiting Student

Naoko Irie

Visiting Student

Matteo Mole

Postdoc Research Scientist

Christopher Penfold

Postdoc Research Scientist

Maria Santos Romero

Postdoc Research Scientist

Amy Wilkinson

PhD Student

Irene Zorzan

Postdoc Research Scientist

Peter Rugg-Gunn

Our group is housed within a large open plan lab that is shared with all members of the Epigenetics Programme. The open setting establishes an exciting dynamic between research groups, often leading to collaborations, training in new methods and interesting discussions. Weekly departmental meetings and seminars reinforce these close interactions.

Outside of Epigenetics, we collaborate closely with several groups within the Lymphocyte and Signalling Programmes, with a particular focus on potential interactions between signalling pathways and epigenetic processes. Our research also benefits greatly from the excellent facilities at the Babraham Institute, with state-of-the-art genomics, flow cytometry, imaging, mass spectrometry and bioinformatics.

​We maintain close links with the University of Cambridge, with affiliations at the WT-MRC Cambridge Stem Cell Institute (www.stemcells.cam.ac.uk) and the Centre for Trophoblast Research (www.trophoblast.cam.ac.uk).

Peter's Career

Peter joined the Babraham Institute in 2011 as a Wellcome Trust Research Career Development Fellow. Peter trained in the laboratories of Roger Pedersen (University of Cambridge) and Janet Rossant (The Hospital for Sick Children, Toronto) where he developed his interest in understanding the epigenetic regulation of stem cells and lineage specification. Peter's research is currently focused on understanding the epigenetic mechanisms that control developmental and stem cell regulation. 

Peter is also involved in the societal impact of stem cell research – working with artists, legal scholars and policy makers to examine the complex ethical and social issues surrounding new biotechnologies such as gene editing in stem cells.

Peter's Group

Our group is housed within a large open plan lab that is shared with all members of the Epigenetics Programme. The open setting establishes an exciting dynamic between research groups, often leading to collaborations, training in new methods and interesting discussions. Weekly departmental meetings and seminars reinforce these close interactions.

Outside of Epigenetics, we collaborate closely with several groups within the Lymphocyte and Signalling Programmes, with a particular focus on potential interactions between signalling pathways and epigenetic processes. Our research also benefits greatly from the excellent facilities at the Babraham Institute, with state-of-the-art genomics, flow cytometry, imaging, mass spectrometry and bioinformatics.

​We maintain close links with the University of Cambridge, with affiliations at the WT-MRC Cambridge Stem Cell Institute (www.stemcells.cam.ac.uk) and the Centre for Trophoblast Research (www.trophoblast.cam.ac.uk).
 

Peter's Career

Peter joined the Babraham Institute in 2011 as a Wellcome Trust Research Career Development Fellow and was awarded tenure by the Institute in 2017. Peter trained in the laboratories of Roger Pedersen (University of Cambridge) and Janet Rossant (The Hospital for Sick Children, Toronto) where he developed his interest in understanding the epigenetic regulation of stem cells and lineage specification. Peter's research is currently focused on understanding the epigenetic mechanisms that control developmental and stem cell regulation. 

Peter is also involved in the societal impact of stem cell research – working with artists, legal scholars and policy makers to examine the complex ethical and social issues surrounding new biotechnologies such as gene editing in stem cells.